Scientist/Senior Research Associate

Specifications Title: Scientist or Senior Research Associate Manager: Associate Director, R&D FLSA: Exempt Classification: Regular full Time Department: Research & Development Location: Brisbane (HQ) Management: n/a General Description We are seeking a highly motivated, critical, and creative Scientist or Senior Research Associate to join the CareDx R&D group. This is an exciting opportunity to be part of a growing, dynamic, and collaborative R&D team innovating cutting-edge technology. The new team member will participate in CareDx research activities with the goal of developing novel cell-free DNA-based tests that address critical clinical unmet needs for transplant patients. Responsibilities as follows, but not necessarily limited to: • Lead cell-free DNA projects to create and develop novel nucleic acid analysis technologies and diagnostic tests for transplant recipients • Plan and efficiently execute complex laboratory experiments with excellent attention to detail • Analyze data in close collaboration with biostatistics and bioinformatics teams • Contribute insight toward experimental design and interpretation as well as troubleshoot laboratory processes and protocols • Keep a detailed laboratory notebook and summarize work in research reports and manuscripts • Interface with staff in multiple departments and clearly communicate results with colleagues and R&D management • Support lab efforts to develop technologies, reagents, and controls necessary for the next generation of CareDx services Work Environment: An employee in this position may work in an environment, or visits facilities, in which safety, environmental and health concerns may demand constant attention. Adherence to the Corporate and/or Plant policies, rules, and regulations in these areas is required. Travel: Travel is not a primary aspect of this position although travel may be requested from time to time. Physical Demands: The physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions. While performing the duties of this job, the employee is regularly required to use hands and fingers, handle or feel, and talk or hear. The employee frequently is required to sit, stand and walk. There will be periods of time during the workday where you will be sitting for 3-4 hours in a row. Regular use of hands to operate office equipment and type on the keyboard will be required. The employee may occasionally lift and/or move up to 25 pounds. Specific vision abilities required by this job include close vision, and ability to adjust focus. CareDx is an Equal Opportunity Employer. • Ph.D. in molecular biology or a related discipline or M.S. with more than 4 years of relevant experience • Strong background in nucleic acid biochemistry and PCR (qPCR, multiplex PCR, and/or digital PCR) • Experience with library preparation for next generation sequencing and evaluation of results • Ability to quickly learn new technologies and incorporate them into your research • Strong grasp of quantitative analysis with a fundamental understanding of statistics • Excellent record keeping and the ability to efficiently work with large data sets • Interest in being part of a vibrant team setting • Industry experience in biotechnology, diagnostics, or life sciences strongly preferred Benefits & Perks: We provide Medical, Dental, Vision and Life Insurance, Flexible Spending and Dependent Care Accounts, Commuter Accounts, 401(k), 3 weeks of vacation, 5 days sick leave, 1 personal floating holiday, 9 paid holidays, gym reimbursement, yoga onsite, ping pong, foosball, BBQ’s, social hours, and more! CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value, non-invasive diagnostic surveillance solutions for transplant recipients. The Company has commercialized AlloMap®, a gene expression test that aids clinicians in identifying heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection. CareDx is also pursuing the development of additional products for post-transplant monitoring of other solid organs that use a variety of technologies, including next-generation sequencing, to detect donor-derived cell-free DNA to monitor the health of organs after transplantation. For more information, please visit: .